UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 4,748 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,358 shares of the company’s stock after purchasing an additional 4,748 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.07% of Definitive Healthcare worth $334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the business. SG Americas Securities LLC boosted its stake in Definitive Healthcare by 44.6% during the fourth quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after acquiring an additional 8,387 shares in the last quarter. Rhumbline Advisers increased its stake in Definitive Healthcare by 5.2% in the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock valued at $334,000 after purchasing an additional 4,034 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Definitive Healthcare by 9.7% during the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock valued at $181,000 after purchasing an additional 3,874 shares during the period. New York State Common Retirement Fund boosted its position in shares of Definitive Healthcare by 3.2% during the 4th quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock worth $3,172,000 after purchasing an additional 23,815 shares in the last quarter. Finally, Ieq Capital LLC bought a new position in shares of Definitive Healthcare during the 4th quarter worth about $51,000. Institutional investors own 98.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DH shares. Wall Street Zen lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 31st. The Goldman Sachs Group raised their price objective on Definitive Healthcare from $3.00 to $3.40 and gave the company a “neutral” rating in a research note on Monday, May 12th. BTIG Research lowered Definitive Healthcare from a “buy” rating to a “neutral” rating in a research report on Friday, May 9th. Finally, Barclays cut their target price on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Definitive Healthcare currently has a consensus rating of “Hold” and a consensus price target of $5.10.

Definitive Healthcare Stock Down 3.2%

Shares of NASDAQ:DH opened at $3.63 on Friday. The business’s 50 day moving average is $3.02 and its 200 day moving average is $3.73. Definitive Healthcare Corp. has a 12-month low of $2.15 and a 12-month high of $6.16. The stock has a market cap of $539.57 million, a price-to-earnings ratio of -1.17, a PEG ratio of 4.06 and a beta of 1.58. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The business had revenue of $59.19 million for the quarter, compared to analysts’ expectations of $56.20 million. During the same period last year, the business earned $0.08 EPS. The business’s revenue was down 6.8% on a year-over-year basis. On average, sell-side analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.